BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Cure 51 S.A.S.

Headquarters: Paris, France
Year Founded: 2022
Status: Private

BioCentury | Sep 5, 2024
Discovery & Translation

AI for target discovery: the start of a long road

Back to School 2024: Investments in AI in drug discovery pick up, as the picture starts to form of how target discovery may benefit
BioCentury | Mar 21, 2024
Finance

Venture report: Mirador’s $400M launch; megarounds for Clasp, Capstan, Engrail

Arch backs immunology/fibrosis start-up; JHU spinout launches with $150M; San Diego-based pair advance clinical plans in oncology and neuroscience
Items per page:
1 - 2 of 2